Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

Clinical Journal of Pain

Volumn 18, Issue 6, 2002, Pages 350-354

  Schmader, Kenneth E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Herpes zoster; Painful diabetic neuropathy; Postherpetic neuralgia

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGE; AGED; ANTIVIRAL ACTIVITY; ANXIETY; DAILY LIFE ACTIVITY; DEPRESSION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE SEVERITY; DISTRESS SYNDROME; ELDERLY CARE; FATIGUE; GLUCOSE BLOOD LEVEL; HERPES ZOSTER; HUMAN; HUMAN RELATION; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; LEISURE; MAJOR CLINICAL STUDY; MOOD DISORDER; PAIN; POSTHERPETIC NEURALGIA; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; REVIEW; RISK FACTOR; SENSORY DYSFUNCTION; SLEEP; UNITED STATES; WORK;

AGE DISTRIBUTION; DIABETIC NEUROPATHIES; HERPES ZOSTER; HUMANS; NEURALGIA; PAIN; PREVALENCE; QUALITY OF LIFE; UNITED STATES;

EID: 0036844605     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200211000-00002     Document Type: Review

References (29)

1. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998 Diabetes Care 2000;23:1278-83.
2. Mokdad AH, Ford ES, Bowman BA, et al. The continuing increase of diabetes in the US. Diabetes Care 2001;24:412-3.
3. Pirart J. Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978;1:168-88.
4. Benbow SJ, Cossins L, MacFarlane IA. Painful diabetic neuropathy. Diabet Med 1999;16:632-44.
5. Boulton AJM, Knight G, Drury J, et al. The prevalence of symptomatic diabetic neuropathy in an insulin-treated population. Diabetes Care 1985;8:125-8.
6. Bulpitt CJ, Shaw KM, Hodes C, et al. The symptom pattern of treated diabetic patients. J Chron Dis 1976;29:571-83.
7. Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. N Engl J Med 1995;333:89-94.
8. Zieglar D, Gries FA, Spuler M, et al. The epidemiology of diabetic neuropathy. J Diabetes Complications 1992;6:49-57.
9. Adler AI, Boyko EJ, Ahroni JH, et al. Risk factors for diabetic peripheral sensory neuropathy: Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997;20:1162-7.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
11. Boulton AJM, Scarpello JHB, Armstrong WD, et al. The natural history of painful diabetic neuropathy - A 4-year study. Postgrad Med J 1983;59:556-9.
12. Benbow SJ, Chan AW, Bowsher D, et al. A prospective study of painful symptoms, small fibre function and peripheral vascular disease in chronic painful peripheral diabetic neuropathy. Diabet Med 1994;11:17-21.
13. Galer BS, Gianas A, Jensen MP. Painful diabetic neuropathy: Epidemiology, pain description and quality of life. Diabetes Res Clin Pract 2000;47:123-8.
14. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831-6.
15. Ware JE, Snow KK, Kosinski M. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: Quality Metric Inc., 2000.
16. Schmader KE. Herpes zoster in older adults. Clin Infect Dis 2001;32:1481-6.
17. Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med 1995;55:1605-9.
18. Helgason S, Sigurdsson JA, Gudmundsson S. The clinical course of herpes zoster: A prospective study in primary care. Eur J Gen Practice 1996;2:12-6.
19. Hope-Simpson RE. The nature of herpes zoster: A long-term study and new hypothesis. Proc R Soc Med (Lond) 1965;58:9-20.
20. Ragozzino MW, Melton LF, Kurland LT. Population-based study of herpes zoster and its sequelae. Medicine 1982;61:310-6.
21. Schmader KE, George LK, Hamilton JD. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995;171:701-5.
22. Dworkin RH, Schmader KE. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson CPN, ed. Herpes Zoster and Postherpetic Neuralgia, 2nd Ed. Amsterdam: Elsevier, 2001:39-65.
23. Choo PW, Galil K, Donahue JG, et al. Risk factors for postherpetic neuralgia. Arch Intern Med 1997;157:1217-24.
24. Dworkin RH, Boon RJ, Griffin DRG, et al. Postherpetic neuralgia: Impact of famciclovir, age, rash severity and acute pain in herpes zoster patients. J Infect Dis 1998;178(Suppl):S76-80.
25. Wood MJ, Kay R, Dworkin RH, et al. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials. Clin Infect Dis 1996;22:341-7.
26. Helgason S, Petursson G, Gudmundsson S, et al. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: Prospective study with long term follow up. BMJ 2000;321:794-6.
27. Watson CPN, Watt VR, Chipman M, et al. The prognosis with postherpetic neuralgia. Pain 1991;46:195-9.
28. Mauskopf J, Austin R, Dix L, Berzon R. The Nottingham Health Profile as a measure of quality of life in zoster patients: Convergent and discriminant validity. Qual Life Res 1994;3:431-5.
29. Coplan P, Schmader K, Nikas A, et al. Evaluation of a modified brief pain inventory to measure pain associated with herpes zoster. Pharmacoepidemiology Drug Safety 2001;10:S149.